Opendata, web and dolomites

HDM-FUN SIGNED

Host directed medicine in invasive fungal infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HDM-FUN project word cloud

Explore the words cloud of the HDM-FUN project. It provides you a very rough idea of what is the project "HDM-FUN" about.

unacceptably    enrolled    transcription    treatment    hpfs    host    inflammasome    genetics    proposes    therapeutic    lethal    overcome    pathogen    phagosome    observational    centrally    managed    regulation    correlate    diagnostic    teaching    biogenesis    outcome    tests    point    infrastructure    setting    centralize    first    translate    scientists    metabolome    infection    protocols    candidemia    signalling    invasive    disease    microbiome    risk    medical    immunology    clinical    infections    biobank    interventions    morbidity    interactions    metabolomics    experimental    personalized    brings    despite    prospective    modulators    health    samples    fungal    susceptibility    patients    ifi    aspergillosis    believe    influenza    directed    trial    mortality    intensive    immunotherapy    trials    hdm    preventive    experts    designing    standardize    prophylaxis    tools    professionals    care    stratify    fun    unravel    strategies    transdisciplinary    efforts    medicine    immune    explore    options   

Project "HDM-FUN" data sheet

The following table provides information about the project.

Coordinator
STICHTING KATHOLIEKE UNIVERSITEIT 

Organization address
address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ
website: www.radboudumc.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 10˙158˙439 €
 EC max contribution 9˙998˙170 € (98%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2019-Two-Stage-RTD
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2024-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) coordinator 2˙811˙150.00
2    IMAGINE INSTITUT DES MALADIES GENETIQUES NECKER ENFANTS MALADES FONDATION FR (PARIS 15) participant 1˙220˙750.00
3    CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS CH (LAUSANNE) participant 703˙000.00
4    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 692˙185.00
5    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 684˙000.00
6    DUKE UNIVERSITY US (DURHAM NC) participant 592˙750.00
7    Hycult biotechnology bv NL (Uden) participant 400˙000.00
8    INNOVATION ACTA S.R.L. IT (ROMA) participant 350˙500.00
9    JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN DE (FRANKFURT AM MAIN) participant 345˙750.00
10    UNIVERSITA DEGLI STUDI DI PERUGIA IT (PERUGIA) participant 322˙450.00
11    THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN UK (ABERDEEN) participant 320˙010.00
12    JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG DE (WUERZBURG) participant 319˙950.00
13    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) participant 319˙750.00
14    LEIBNIZ-INSTITUT FUR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE EV HANS-KNOLL-ISTITUT DE (JENA) participant 319˙700.00
15    UNIVERSIDADE DO MINHO PT (BRAGA) participant 319˙625.00
16    UNIVERSITATEA DE MEDICINA SI FARMACIE IULIU HATIEGANU CLUJ-NAPOCA RO (Cluj-Napoca) participant 276˙600.00

Map

 Project objective

Despite novel treatment options and development of diagnostic tools invasive fungal infections (IFI) are still associated with an unacceptably high mortality and morbidity. Experts believe that a host directed approach is needed to overcome this problem. HDM-FUN proposes a transdisciplinary approach to identify host-pathogen factors (HPFs) needed for host directed medical interventions in IFI and will be the first of its kind. The overall concept is to identify host-pathogen factors in the setting of immunotherapy and prophylaxis that will allow the design for tailored novel therapeutic and preventive host-directed medicine approaches for patients with lethal invasive fungal infection in the intensive care. Specific objectives: 1. To identify host-pathogen factors that correlate with disease, and correlate them with preventive or immunotherapy- based strategies to stratify patients for personalized host-directed treatment options. 2. Two clinical trials of host-directed medicine approaches; an immunotherapy trial in patients with candidemia and a prospective observational trial for prophylaxis in patients with influenza at risk for aspergillosis. 3. To set-up a centrally managed biobank with samples of the patients enrolled in both clinical trials, and to standardize experimental procedures, protocols and centralize analysis. 4. To establish a unique infrastructure aimed to: explore host-directed medicine approaches in IFI, evaluate their impact on patients and health care, translate research efforts to clinical practice by designing point of care tests and teaching medical professionals. HDM-FUN brings together top scientists and clinical researchers to unravel host factors (genetics and transcription), immune modulators (metabolome, microbiome), and host pathogen interactions (genetics, metabolomics, immunology, signalling pathways, phagosome biogenesis, and inflammasome regulation) that determine the susceptibility and outcome of patients with fungal infection.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HDM-FUN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HDM-FUN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More